1. Home
  2. GRND vs ENOV Comparison

GRND vs ENOV Comparison

Compare GRND & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grindr Inc.

GRND

Grindr Inc.

HOLD

Current Price

$11.25

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$22.44

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRND
ENOV
Founded
2009
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Fluid Controls
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
GRND
ENOV
Price
$11.25
$22.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$22.75
$48.13
AVG Volume (30 Days)
1.7M
1.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$29.03
$9.18
Revenue Next Year
$21.87
$4.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.79
$21.00
52 Week High
$25.13
$43.75

Technical Indicators

Market Signals
Indicator
GRND
ENOV
Relative Strength Index (RSI) 51.00 44.89
Support Level $9.79 $21.00
Resistance Level $14.12 $23.57
Average True Range (ATR) 0.52 1.04
MACD 0.18 0.22
Stochastic Oscillator 84.31 52.07

Price Performance

Historical Comparison
GRND
ENOV

About GRND Grindr Inc.

Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: